https://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/news/FDA-Rejects-Regeneron-s-Odronextamab-in-Follicular-Diffuse-Large-B-cell-Lymphoma-46275346/?utm_source=telegram&utm_medium=social&utm_campaign=share